Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

ASCO Genitourinary Cancers Symposium
W

ASCO GU 2022 on Gem & Cis as Neoadjuvant Chemo in High-Grade UTUC: Final Results of a Multicenter Prospective Phase II Clinical Trial

By ASCO Genitourinary Cancers Symposium FEATURING Wesley Yip
By ASCO Genitourinary Cancers Symposium FEATURING Wesley Yip
92 views
February 28, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
Genitourinary
25:32

Multidisciplinary Approaches for Muscle Invasive Bladder Cancer

Memorial Sloan Kettering Cancer Center

B. Bochner

201 views
29:46

Clinical Perspectives on Managing Hereditary Kidney Cancer

Memorial Sloan Kettering Cancer Center

J. Coleman

53 views
06:55

ASCO® GU 2024 Insights: "HER2 and PD-L1 Immunohistochemistry Express…

Insights from 2024 ASCO® GU Annual Meeting

D. Aggen

112 views
08:56

ESMO 2023 Insights: "MEDI5752 (Volrustomig) in the 1L Treatment of P…

Insights from 2023 ESMO Annual Meeting

M. Voss

132 views
24:28

The Best of GU Radiation Oncology

OncoAlert

S. McBride

278 views
46:48

Theranostics and the Changing Face of Prostate Cancer

University of Colorado Cancer Center

M. Morris

248 views
08:05

ASCO 2022: A Phase II Study of Gem + Cis Chemo in MIBC With Bladder …

ASCO 2022 Conference Coverage

G. Iyer

131 views
44

Lecture Summary - Results of Phase II Clinical Trial of Cabozantinib…

Memorial Sloan Kettering Cancer Center

C. Lee

18 views
07:31

Results of Phase II Clinical Trial of Cabozantinib + Nivolumab for A…

Memorial Sloan Kettering Cancer Center

C. Lee

76 views
06:49

ASCO GU 2022 on Gem & Cis as Neoadjuvant Chemo in High-Grade UTUC: F…

ASCO Genitourinary Cancers Symposium

W. Yip

92 views
06:24

ASCO 2021 Update on mCRPC: VISION Trial Data on Lutetium-177-PSMA-617

ecancer

M. Morris

39 views
04:46
Memorial Sloan Kettering Cancer Center

2020 Update on mRCC: Lenvatinib + Pembro After CPIs: Is There a Bene…

Feat. C. Lee